187 related articles for article (PubMed ID: 15148857)
1. Blood phenylalanine control in adolescents with phenylketonuria.
Walter JH; White FJ
Int J Adolesc Med Health; 2004; 16(1):41-5. PubMed ID: 15148857
[TBL] [Abstract][Full Text] [Related]
2. An automated enzymatic method on the Roche COBAS MIRA S for monitoring phenylalanine in dried blood spots of patients with phenylketonuria.
Randell EW; Lehotay DC
Clin Biochem; 1996 Apr; 29(2):133-8. PubMed ID: 8601321
[TBL] [Abstract][Full Text] [Related]
3. Work activity and phenylalanine levels in a population of young adults with classic PKU.
Riva MA; Madotto F; Turato M; Salvatici E; Indovina S; Giovannini M; Riva E; Cesana G
Med Lav; 2017 Apr; 108(2):118-122. PubMed ID: 28446738
[TBL] [Abstract][Full Text] [Related]
4. Adherence to clinic recommendations among patients with phenylketonuria in the United States.
Jurecki ER; Cederbaum S; Kopesky J; Perry K; Rohr F; Sanchez-Valle A; Viau KS; Sheinin MY; Cohen-Pfeffer JL
Mol Genet Metab; 2017 Mar; 120(3):190-197. PubMed ID: 28162992
[TBL] [Abstract][Full Text] [Related]
5. Therapy compliance in children with phenylketonuria younger than 5 years: A cohort study.
Walkowiak D; Bukowska-Posadzy A; Kałużny Ł; Ołtarzewski M; Staszewski R; Musielak M; Walkowiak J
Adv Clin Exp Med; 2019 Oct; 28(10):1385-1391. PubMed ID: 31469949
[TBL] [Abstract][Full Text] [Related]
6. Plasma cholesterol in adults with phenylketonuria.
Williams RA; Hooper AJ; Bell DA; Mamotte CD; Burnett JR
Pathology; 2015 Feb; 47(2):134-7. PubMed ID: 25551302
[TBL] [Abstract][Full Text] [Related]
7. Blood-brain phenylalanine relationships in persons with phenylketonuria.
Koch R; Moats R; Guttler F; Guldberg P; Nelson M
Pediatrics; 2000 Nov; 106(5):1093-6. PubMed ID: 11061780
[TBL] [Abstract][Full Text] [Related]
8. Induction, titration, and maintenance dosing regimen in a phase 2 study of pegvaliase for control of blood phenylalanine in adults with phenylketonuria.
Zori R; Thomas JA; Shur N; Rizzo WB; Decker C; Rosen O; Li M; Schweighardt B; Larimore K; Longo N
Mol Genet Metab; 2018 Nov; 125(3):217-227. PubMed ID: 30146451
[TBL] [Abstract][Full Text] [Related]
9. Stability of blood phenylalanine levels and IQ in children with phenylketonuria.
Anastasoaie V; Kurzius L; Forbes P; Waisbren S
Mol Genet Metab; 2008; 95(1-2):17-20. PubMed ID: 18703366
[TBL] [Abstract][Full Text] [Related]
10. "MY PKU": increasing self-management in patients with phenylketonuria. A randomized controlled trial.
Ten Hoedt AE; Hollak CE; Boelen CC; van der Herberg-van de Wetering NA; Ter Horst NM; Jonkers CF; Wijburg FA; Bosch AM
Orphanet J Rare Dis; 2011 Jun; 6():48. PubMed ID: 21708003
[TBL] [Abstract][Full Text] [Related]
11. Blood phenylalanine control in phenylketonuria: a survey of 10 European centres.
Ahring K; Bélanger-Quintana A; Dokoupil K; Gokmen-Ozel H; Lammardo AM; MacDonald A; Motzfeldt K; Nowacka M; Robert M; van Rijn M
Eur J Clin Nutr; 2011 Feb; 65(2):275-8. PubMed ID: 21119696
[TBL] [Abstract][Full Text] [Related]
12. Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets.
Weigel C; Kiener C; Meier N; Schmid P; Rauh M; Rascher W; Knerr I
Ann Nutr Metab; 2008; 53(2):91-5. PubMed ID: 18946205
[TBL] [Abstract][Full Text] [Related]
13. Executive functioning in children and adolescents with phenylketonuria.
VanZutphen K; Packman W; Sporri L; Needham M; Morgan C; Weisiger K; Packman S
Clin Genet; 2007 Jul; 72(1):13-8. PubMed ID: 17594394
[TBL] [Abstract][Full Text] [Related]
14. Factors that increase risk for poor adherence to phenylketonuria treatment in Brazilian patients.
Teruya KI; Remor E; Schwartz IVD
Am J Med Genet A; 2021 Jul; 185(7):1991-2002. PubMed ID: 33765361
[TBL] [Abstract][Full Text] [Related]
15. Reassessment of phenylalanine tolerance in adults with phenylketonuria is needed as body mass changes.
MacLeod EL; Gleason ST; van Calcar SC; Ney DM
Mol Genet Metab; 2009 Dec; 98(4):331-7. PubMed ID: 19747868
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment of phenylketonuria with a new medical food containing large neutral amino acids.
Concolino D; Mascaro I; Moricca MT; Bonapace G; Matalon K; Trapasso J; Radhakrishnan G; Ferrara C; Matalon R; Strisciuglio P
Eur J Clin Nutr; 2017 Jan; 71(1):51-55. PubMed ID: 27623981
[TBL] [Abstract][Full Text] [Related]
17. Outcomes beyond phenylalanine: an international perspective.
Feillet F; MacDonald A; Hartung Perron D; Burton B
Mol Genet Metab; 2010; 99 Suppl 1():S79-85. PubMed ID: 20123476
[TBL] [Abstract][Full Text] [Related]
18. Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control?
Daly A; Evans S; Chahal S; Santra S; MacDonald A
J Hum Nutr Diet; 2017 Aug; 30(4):515-523. PubMed ID: 28111827
[TBL] [Abstract][Full Text] [Related]
19. Does maternal knowledge impact blood phenylalanine concentration in Turkish children with phenylketonuria?
Ozel HG; Kucukkasap T; Koksal G; Sivri HS; Dursun A; Tokatli A; Coskun T
J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S213-7. PubMed ID: 18581253
[TBL] [Abstract][Full Text] [Related]
20. Intelligence in mild atypical phenylketonuria.
Costello PM; Beasley MG; Tillotson SL; Smith I
Eur J Pediatr; 1994 Apr; 153(4):260-3. PubMed ID: 8194559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]